The U.S. Food and Drug Administration on Wednesday amended the emergency use authorizations of the Moderna and Pfizer-BioNTech COVID-19 vaccines to authorize updated boosters to combat omicron ...

Pfizer and BioNTech released more human data Friday indicating the omicron BA.5 boosters perform better than the old Covid shots. Stream NBC 5 for free, 24/7, wherever you are. People older than 55 ...

WASHINGTON -- The US Food and Drug Administration gave the green light Monday to updated COVID-19 vaccines from Moderna and Pfizer/BioNTech amid rising cases and hospitalizations. Both vaccine ...

LONDON (AP) — The European Medicines Agency has recommended the authorization of a tweaked booster dose of the Pfizer-BioNTech coronavirus vaccine that includes protection against two of the latest ...

The U.S. on Wednesday authorized its first update to COVID-19 vaccines, booster doses that target today's most common omicron strain. Shots could begin within days. The move by the Food and Drug ...

Pfizer asked U.S. regulators Monday to expand use of its updated COVID-19 booster shot to children ages 5 to 11. Elementary school-aged children already received kid-sized doses of Pfizer’s original ...

The US Food and Drug Administration has granted emergency use authorization for a booster dose of Pfizer/BioNTech's COVID-19 vaccine for children ages 5 to 11 at least five months after completion of ...

Pfizer Inc. (PFE) and BioNTech SE (BNTX) announced on Monday that their updated COVID-19 vaccine elicited a robust immune response in a late-stage trial among adults aged 65 and older, as well as ...

NEW YORK, N.Y. — Pfizer and BioNTech announced Tuesday that they’ve made a request for the Food and Drug Administration (FDA) to authorize their COVID-19 booster shot for all adults. Specifically, the ...

Pfizer and BioNTech said a key European regulatory committee recommended approval of an updated version of their updated Comirnaty Covid-19 vaccine that targets the LP.8.1 strain. The companies on ...